Often, public financial management (PFM) systems contain barriers that impede the effective purchasing and provision of TB services from care to treatment, resulting in poorer health outcomes for the most vulnerable populations. This can result in cases of TB left unrecognized when providers are not incentivized to screen for it, or high levels of drug resistance as a result of poorly implemented treatment regimes.